Abstract:Nanoparticles are widely used in various biomedical applications as drug delivery carriers, imaging probes, single-molecule tracking/detection probes, artificial chaperones for inhibiting protein aggregation, and photodynamic therapy materials. One key parameter of these applications is the ability of the nanoparticles to enter into the cell cytoplasm, target different subcellular compartments, and control intracellular processes. This is particularly the case because nanoparticles are designed to interact with subcellular components for the required biomedical performance. However, cells are protected from their surroundings by the cell membrane, which exerts strict control over entry of foreign materials. Thus, nanoparticles need to be designed appropriately so that they can readily cross the cell membrane, target subcellular compartments, and control intracellular processes.In the past few decades there have been great advancements in understanding the principles of cellular uptake of foreign materials. In particular, it has been shown that internalization of foreign materials (small molecules, macromolecules, nanoparticles) is size-dependent: endocytotic uptake of materials requires sizes greater than 10 nm, and materials with sizes of 10-100 nm usually enter into cells by energy-dependent endocytosis via biomembrane-coated vesicles. Direct access to the cytosol is limited to very specific conditions, and endosomal escape of material appears to be the most practical approach for intracellular processing.In this Account, we describe how cellular uptake and intracellular processing of nanoscale materials can be controlled by appropriate design of size and surface chemistry. We first describe the cell membrane structure and principles of cellular uptake of foreign materials followed by their subcellular trafficking. Next, we discuss the designed surface chemistry of a 5-50 nm particle that offers preferential lipid-raft/caveolae-mediated endocytosis over clathrin-mediated endocytosis with minimum endosomal/lysosomal trafficking or energy-independent direct cell membrane translocation (without endocytosis) followed by cytosolic delivery without endosomal/lysosomal trafficking. In particular, we emphasize that the zwitterionic-lipophilic surface property of a nanoparticle offers preferential interaction with the lipid raft region of the cell membrane followed by lipid raft uptake, whereas a lower number of affinity biomolecules (<25) on the nanoparticle surface offers caveolae/lipid-raft uptake, while an arginine/guanidinium-terminated surface along with a size of <10 nm offers direct cell membrane translocation. Finally, we discuss how nanoprobes can be designed by adapting these surface chemistry and size preference principles so that they can readily enter into the cell, label different subcellular compartments, and control intracellular processes such as trafficking kinetics, exocytosis, autophagy, amyloid aggregation, and clearance of toxic amyloid aggregates. The Account ends with a Conclusions and Outlook where we discuss a vision for the development of subcellular targeting nanodrugs and imaging nanoprobes by adapting to these surface chemistry principles.

Emerging Applications of Nanotechnology for Controlling Cell-Surface Receptor Clustering.

Nanoparticle Ligand Exchange and Its Effects at the Nanoparticle-Cell Membrane Interface

Reversible control of cell membrane receptor function using DNA nano-spring multivalent ligands.

Nanotopographical Surfaces for Stem Cell Fate Control: Engineering Mechanobiology from the Bottom

The development of site-specific drug delivery nanocarriers based on receptor mediation.

Cyto-friendly Polymerization at Cell Surfaces Modulates Cell Fate by Clustering Cell-Surface Receptors.

Controlling the Chemistry of Nanoclusters: From Atomic Precision to Controlled Assembly

New Opportunities: The Use of Nanotechnologies to Manipulate and Track Stem Cells

Nanostructured Interfaces with RGD Arrays to Control Cell–matrix Interaction

Nanomanipulation of Ligand Nanogeometry Modulates Integrin/Clathrin-Mediated Adhesion and Endocytosis of Stem Cells

Interplay Between G Protein-Coupled Receptors and Nanotechnology

Spatiotemporal control of cell-cell reversible interactions using molecular engineering

Nano–bio effects: interaction of nanomaterials with cells

Surface Ligands in Synthesis, Modification and Assembly of Nanoparticles for Biomedical Applications

Chemically Designed Nanoscale Materials for Controlling Cellular Processes

Principles of regulating particle multiscale structures for controlling particle-cell interaction process

Multifaceted Applications of Nanomaterials in Cell Engineering and Therapy

DNA-modulated dimerization and oligomerization of cell membrane receptors

Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications

Spatially Reprogramed Receptor Organization to Switch Cell Behavior Using a DNA Origami-Templated Aptamer Nanoarray

Creation of Nanostructures by Interference Lithography for Modulation of Cell Behavior